(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 6.92% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.26%.
Tilray Brands's revenue in 2025 is $826,656,000.On average, 5 Wall Street analysts forecast TLRY's revenue for 2026 to be $905,337,046,461, with the lowest TLRY revenue forecast at $876,959,900,324, and the highest TLRY revenue forecast at $943,086,682,662. On average, 3 Wall Street analysts forecast TLRY's revenue for 2027 to be $963,149,165,955, with the lowest TLRY revenue forecast at $920,339,874,734, and the highest TLRY revenue forecast at $1,003,476,438,222.
In 2028, TLRY is forecast to generate $1,015,655,038,927 in revenue, with the lowest revenue forecast at $968,450,379,997 and the highest revenue forecast at $1,062,859,697,856.